STAND. COM. REP. NO. 1322-18

Honolulu, Hawaii

, 2018

RE: S.B. No. 2659

S.D. 1

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sir:

Your Committee on Consumer Protection & Commerce, to which was referred S.B. No. 2659, S.D. 1, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO MEDICAL CANNABIS PRODUCTS,"

begs leave to report as follows:

The purpose of this measure is to update the list of cannabis products that may be manufactured and distributed by licensed medical cannabis dispensaries to include transdermal delivery devices, not limited to transdermal patches and cannabinoid suppositories, based on recommendations of the Medical Cannabis Legislative Oversight Working Group.

Oahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i and Drug Policy Forum of Hawaii supported this measure. The Department of Health offered comments on this measure.

As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2659, S.D. 1, H.D. 1, and recommends that it be referred to your Committee on Finance.

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

____________________________

ROY M. TAKUMI, Chair